In the original article, the reference for 118 was incorrectly written as:
“Johnston SRD, Hegg R, Im SA, Park IH, Burdaeva O, Kurteva G, et al. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2018;36(8):741-8.”
It should be
“Johnston SRD, Hegg R, Im SA, Park IH, Burdaeva O, Kurteva G, et al. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2‐Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE. J Clin Oncol. 2021;39(1):79–89. doi: 10.1200/JCO.20.01894.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
early breast cancer, locally advanced breast cancer, adjuvant treatment, neoadjuvant treatment, metastatic breast cancer, inflammatory breast cancer, guideline
Citation
Rubovszky G, Kocsis J, Boér K, Chilingirova N, Dank M, Kahán Z, Kaidarova D, Kövér E, Krakovská BV, Máhr K, Mriňáková B, Pikó B, Božović-Spasojević I and Horváth Z (2023) Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer. Pathol. Oncol. Res. 29:1610954. doi: 10.3389/pore.2023.1610954
Received
18 November 2022
Accepted
19 January 2023
Published
31 January 2023
Volume
29 - 2023
Edited by
Andrea Ladányi, National Institute of Oncology (NIO), Hungary
Updates
Copyright
© 2023 Rubovszky, Kocsis, Boér, Chilingirova, Dank, Kahán, Kaidarova, Kövér, Krakovská, Máhr, Mriňáková, Pikó, Božović-Spasojević and Horváth.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Gábor Rubovszky, rubovszkyg@gmail.com
†These authors have contributed equally to this work and share first authorship
Panel members are listed in the Supplementary Appendix
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.